| Michele Ramsdell, | |
|
3601 W 13 Mile Rd, Royal Oak, MI 48073-6712 | |
| (248) 551-4954 | |
| Not Available |
| Full Name | Michele Ramsdell |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 30 Years |
| Location | 3601 W 13 Mile Rd, Royal Oak, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699736728 | NPI | - | NPPES |
| 4266905 | Medicaid | MI | |
| 300F362420 | Other | MI | BCBSM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301063198 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital - Grosse Pointe | Grosse pointe, MI | Hospital |
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beaumont Medical Group Hospital Based Services | 3072875889 | 457 |
News Archive
A paper in this week's issue of The Lancet highlights how two tobacco companies attempted to influence plans to privatise the state-owned tobacco industry in Moldova.
In a comprehensive systemic analysis of different studies, researchers have found that physical distancing, use of face masks, and eye protection were the most effective ways to prevent the spread of SARS-CoV-2 infection from one person to another.
Halloween candy is nearly synonymous with cavities, especially if you or your children have a fondness for sour and sticky sweets.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
› Verified 7 days ago
| Entity Name | Beaumont Medical Group Hospital Based Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427567858 PECOS PAC ID: 3072875889 Enrollment ID: O20180314001796 |
News Archive
A paper in this week's issue of The Lancet highlights how two tobacco companies attempted to influence plans to privatise the state-owned tobacco industry in Moldova.
In a comprehensive systemic analysis of different studies, researchers have found that physical distancing, use of face masks, and eye protection were the most effective ways to prevent the spread of SARS-CoV-2 infection from one person to another.
Halloween candy is nearly synonymous with cavities, especially if you or your children have a fondness for sour and sticky sweets.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michele Ramsdell, 26901 Beaumont Blvd Ste 3d, Southfield, MI 48033-3849 Ph: (947) 522-1863 | Michele Ramsdell, 3601 W 13 Mile Rd, Royal Oak, MI 48073-6712 Ph: (248) 551-4954 |
News Archive
A paper in this week's issue of The Lancet highlights how two tobacco companies attempted to influence plans to privatise the state-owned tobacco industry in Moldova.
In a comprehensive systemic analysis of different studies, researchers have found that physical distancing, use of face masks, and eye protection were the most effective ways to prevent the spread of SARS-CoV-2 infection from one person to another.
Halloween candy is nearly synonymous with cavities, especially if you or your children have a fondness for sour and sticky sweets.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, today announced the results of an animal study that further demonstrates the company's Phase II oncology drug, Archexin™, as having the potential to target and treat multiple life-threatening cancers.
› Verified 7 days ago
Terrence Metz, Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-5000 | |
Christopher W Keyes, MD Radiology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-7266 | |
Stephen Hudak, Radiology Medicare: Not Enrolled in Medicare Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-6262 | |
Elias Antypas, Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6509 | |
Dr. Derek Alexander Mumaw, MD Radiology Medicare: Medicare Enrolled Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-551-6347 | |
Kent Donovan, Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6509 | |
Dr. John Douglas Ebersole, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3601 W 13 Mile Rd, Royal Oak, MI 48073 Phone: 248-898-6064 |